Vistagen to present at jefferies inaugural biotech cns/neuro summit

South san francisco, calif.--(business wire)---- $vtgn #mentalhealth--vistagen (nasdaq: vtgn), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (cns) disorders, today announced that the company will present and host one-on-one meetings at the jefferies biotech cns/neuro summit taking place october 11 – 12, 2023 in new york city, new york. jefferies inaugural biotech cns/neuro summit details fire.
VTGN Ratings Summary
VTGN Quant Ranking